| IBM | 60.0 | 36 | 0 |
| socially responsible investing | 40.0 | 0 | 7 |
| Merrill | 38.2 | 1 | 3 |
| Royal Bank of Canada | 37.4 | 0 | 6 |
| eToro | 32.3 | 6 | 0 |
| Financial Advisor | 31.6 | 2 | 1 |
| Data Analytics for Machine Learning | 29.8 | 5 | 0 |
| Jordan/Zalaznick Advisers Inc. | 26.7 | 4 | 0 |
| Journal of Real Estate Portfolio Management | 26.7 | 0 | 3 |
| Success | 23.0 | 3 | 0 |
| IBM Bluemix | 23.0 | 3 | 0 |
| mutual fund | 21.1 | 0 | 2 |
| money market fund | 21.1 | 0 | 2 |
| Ave Maria Mutual Funds | 21.1 | 0 | 2 |
| Amana Mutual Funds Trust | 21.1 | 0 | 2 |
| Locked-In Retirement Account | 21.1 | 0 | 2 |
| Category:Mutual funds | 21.1 | 0 | 2 |
| mutual fund fees and expenses | 21.1 | 0 | 2 |
| Robo-advisor | 21.1 | 0 | 2 |
| Edelweiss Broking Limited | 21.1 | 0 | 2 |
| The Opportunity Cost of Negative Screening in Socially Responsible Investing | 21.1 | 0 | 2 |
| The effects of corporate governance on environmental sustainability reporting: empirical evidence from South Asian countries | 21.1 | 0 | 2 |
| Corporate governance in Islamic financial institutions: the issues surrounding unrestricted investment account holders | 21.1 | 0 | 2 |
| 2018-26 - SEC Charges Ameriprise With Overcharging Retirement Account Customers for Mutual Fund Shares (NAID 144012257) | 21.1 | 0 | 2 |
| 2008-157 - SEC Charges Mutual Fund Manager for Violating Socially Responsible Investing Restrictions (NAID 144006943) | 21.1 | 0 | 2 |
| 2007-40 - SEC and U.S. Attorney Charge Three Offshore Hackers with Hijacking Online Brokerage Accounts, Manipulating Market (NAID 144006169) | 21.1 | 0 | 2 |
| 2005-158 - SEC Urges Investors to Protect Their Online Brokerage Accounts from Identity Thieves (NAID 144005593) | 21.1 | 0 | 2 |
| 2003-135 - SEC and U.S. Attorney Charge Computer Hacker With Fraud in Online Securities Scam; Teen Hacks Into Westborough Man's Online Brokerage Account, Places Unauthorized Buy Orders for Own Securities (NAID 144004827) | 21.1 | 0 | 2 |
| 2002-139 - Commission Proposes Disclosure of Proxy Voting by Mutual Funds, Investment Advisers (NAID 144004473) | 21.1 | 0 | 2 |
| Mutual fund investing: what you need to consider when choosing your mutual funds | 21.1 | 0 | 2 |
| Goethe-Universität Frankfurt am Main Lehrstuhl für Investment Portfolio Management und Alterssicherung | 21.1 | 0 | 2 |
| Webull | 21.1 | 0 | 2 |
| Institutional Investors and Proxy Voting on Compensation Plans: The Impact of the 2003 Mutual Fund Voting Disclosure Regulation | 21.1 | 0 | 2 |
| Does mutual fund investment style consistency affect the performance of mutual funds? : evidence from Chinese mutual funds | 21.1 | 0 | 2 |
| The Relationship Between Corporate Governance Quality and Sustainability Reporting: An Analysis of Top Performing Companies and Financially Distressed Companies | 21.1 | 0 | 2 |
| The Effect of Information Disclosure on Corporate Governance and Mutual Funds | 21.1 | 0 | 2 |
| Four essays on capital structure dynamics: special reference to level of leverage, state ownership, corporate governance and climate risk | 21.1 | 0 | 2 |
| The impact of ethical ratings on Canadian security performance: Portfolio management and corporate governance implications | 21.1 | 0 | 2 |
| Michael Kashani | 21.1 | 0 | 2 |
| Extreme Positive Payoffs and Mutual Fund Flows:Empirical Analysis Based on Chinese Mutual Funds | 21.1 | 0 | 2 |
| Empirical Study on the Relationship between Corporate Governance and Investment Decision of Mutual Funds——Evidence from Chinese Listed Firms | 21.1 | 0 | 2 |
| Investment portfolio management based on the two-step kernel estimator of CVaR | 21.1 | 0 | 2 |
| No accounting for corporate governance: proxy voting with securities lending | 21.1 | 0 | 2 |
| Moomoo | 21.1 | 0 | 2 |
| Is there a relationship between Morningstar’s ESG ratings and mutual fund performance? | 21.1 | 0 | 2 |
| Optimization of investment portfolio management | 21.1 | 0 | 2 |
| Passive ESG Portfolio Management - The Benchmark Strategy for Socially Responsible Investors | 21.1 | 0 | 2 |
| Negative screening and sustainable portfolio diversification | 21.1 | 0 | 2 |
| Mutual fund board connections and proxy voting | 21.1 | 0 | 2 |
| Sustainable Investment: Interrelated among Corporate Governance, Economic Performance and Market Risks Using Investor Preference Approach | 21.1 | 0 | 2 |
| The Role of Mutual Funds in Corporate Governance Processes Among Listed Companies in Poland | 21.1 | 0 | 2 |
| The effect of green bonds on climate risk amid economic and environmental policy uncertainties | 21.1 | 0 | 2 |
| Corporate governance and environmental social governance disclosure: A meta‐analytical review | 21.1 | 0 | 2 |
| The next frontier for measurement and evaluation: Social impact measurement for impact investing and market solutions | 21.1 | 0 | 2 |
| The Role of Public Pension Funds in Corporate Governance: Evidence from Proxy Voting | 21.1 | 0 | 2 |
| Sustainable portfolio management under climate change | 21.1 | 0 | 2 |
| Perspective of corporate governance and ethical issues with profit sharing investment accounts in Islamic banks | 21.1 | 0 | 2 |
| Q131898703 | 21.1 | 0 | 2 |
| Q134891607 | 21.1 | 0 | 2 |
| Q135905392 | 21.1 | 0 | 2 |
| PortfolioX | 21.1 | 0 | 2 |
| Julian B. Morris | 21.1 | 0 | 2 |
| Real Value Portfolio Management & Marketing | 21.1 | 0 | 2 |
| SPSS | 18.3 | 2 | 0 |
| JPMorgan Chase | 18.3 | 2 | 0 |
| UBS | 18.3 | 2 | 0 |
| Programme for International Student Assessment | 18.3 | 2 | 0 |
| Bloomberg Businessweek | 18.3 | 2 | 0 |
| The Vanguard Group | 18.3 | 2 | 0 |
| IBM Informix | 18.3 | 2 | 0 |
| Schroders | 18.3 | 2 | 0 |
| CICS | 18.3 | 2 | 0 |
| IBM Rational DOORS | 18.3 | 2 | 0 |
| Ecosia | 18.3 | 2 | 0 |
| Fidelity Investments | 18.3 | 2 | 0 |
| Rational Rhapsody | 18.3 | 2 | 0 |
| IBM Power Systems | 18.3 | 2 | 0 |
| Bloomberg Terminal | 18.3 | 2 | 0 |
| CPLEX | 18.3 | 2 | 0 |
| TALIS | 18.3 | 2 | 0 |
| IBM Configuration Management Version Control | 18.3 | 2 | 0 |
| Credit Karma | 18.3 | 2 | 0 |
| NerdWallet.com | 18.3 | 2 | 0 |
| TreeHugger | 18.3 | 2 | 0 |
| OECD Main Economic Indicators | 18.3 | 2 | 0 |
| Merrill Edge | 18.3 | 2 | 0 |
| Multilateral Convention to Implement Tax Treaty Related Measures to Prevent Base Erosion and Profit Shifting | 18.3 | 2 | 0 |
| CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows | 18.3 | 2 | 0 |
| Q56254773 | 18.3 | 2 | 0 |
| bidirectional encoder representations from transformers | 18.3 | 2 | 0 |
| NASDAQ/Ngs (Global Select Market) | 18.3 | 2 | 0 |
| UBS Securities LLC | 18.3 | 2 | 0 |
| IBM Cloud | 18.3 | 2 | 0 |
| The David Rubenstein Show | 18.3 | 2 | 0 |
| Trading 212 UK Limited | 18.3 | 2 | 0 |
| Bloomberg Bpool | 18.3 | 2 | 0 |
| IBM Cloud Object Storage | 18.3 | 2 | 0 |
| SPARQL Generation: an analysis on fine-tuning OpenLLaMA for Question Answering over a Life Science Knowledge Graph | 18.3 | 2 | 0 |
| Wikimedia Foundation | 13.3 | 0 | 1 |
| share | 13.3 | 0 | 1 |
| Martin Blessing | 13.3 | 0 | 1 |
| Mahara | 13.3 | 0 | 1 |
| Q193635 | 13.3 | 0 | 1 |
| carbon footprint | 13.3 | 0 | 1 |
| OVB Holding | 13.3 | 0 | 1 |
| corporate governance | 13.3 | 0 | 1 |
| Edward Johnson, III | 13.3 | 0 | 1 |
| Morgan Stanley Wealth Management | 13.3 | 0 | 1 |
| asset allocation | 13.3 | 0 | 1 |
| Mary Callahan Erdoes | 13.3 | 0 | 1 |
| absentee ballot | 13.3 | 0 | 1 |
| financial adviser | 13.3 | 0 | 1 |
| trading halt | 13.3 | 0 | 1 |
| exchange-traded fund | 13.3 | 0 | 1 |
| private banking | 13.3 | 0 | 1 |
| Clarity | 13.3 | 0 | 1 |
| corporate governance of information technology | 13.3 | 0 | 1 |
| Peter Lynch | 13.3 | 0 | 1 |
| Daniel Wermelinger | 13.3 | 0 | 1 |
| Nagoya Stock Exchange | 13.3 | 0 | 1 |
| proxy voting | 13.3 | 0 | 1 |
| index fund | 13.3 | 0 | 1 |
| Q1204700 | 13.3 | 0 | 1 |
| Dodge & Cox | 13.3 | 0 | 1 |
| Saxo Bank A/S | 13.3 | 0 | 1 |
| Demeny voting | 13.3 | 0 | 1 |
| European Financial Reporting Advisory Group | 13.3 | 0 | 1 |
| Borsa Istanbul | 13.3 | 0 | 1 |
| Financial Markets and Portfolio Management | 13.3 | 0 | 1 |
| Florencio López de Silanes | 13.3 | 0 | 1 |
| proxy voting | 13.3 | 0 | 1 |
| carbon emission label | 13.3 | 0 | 1 |
| ISO 21500 | 13.3 | 0 | 1 |
| integrated management system | 13.3 | 0 | 1 |
| International Institute for Sustainable Development | 13.3 | 0 | 1 |
| sustainability reporting | 13.3 | 0 | 1 |
| Multi-project management | 13.3 | 0 | 1 |
| Jürg Zeltner | 13.3 | 0 | 1 |
| Nostro account | 13.3 | 0 | 1 |
| carbon neutrality | 13.3 | 0 | 1 |
| Schoellerbank | 13.3 | 0 | 1 |
| Melrose Bickerstaff | 13.3 | 0 | 1 |
| project portfolio management | 13.3 | 0 | 1 |
| Planforge | 13.3 | 0 | 1 |
| Portfolio management | 13.3 | 0 | 1 |
| European Corporate Governance Network | 13.3 | 0 | 1 |
| Code-Tabaksblat | 13.3 | 0 | 1 |
| Q2372905 | 13.3 | 0 | 1 |
| Wealth Management Capital Holding | 13.3 | 0 | 1 |
| securities account | 13.3 | 0 | 1 |
| investment strategy | 13.3 | 0 | 1 |
| mutualism | 13.3 | 0 | 1 |
| Application Portfolio Management | 13.3 | 0 | 1 |
| Convertible security | 13.3 | 0 | 1 |
| Certified International Wealth Management | 13.3 | 0 | 1 |
| Investment Financial Advisor (France) | 13.3 | 0 | 1 |
| Corporate Governance of ICT | 13.3 | 0 | 1 |
| Indosuez Wealth Management | 13.3 | 0 | 1 |
| Strategic sustainable investing | 13.3 | 0 | 1 |
| Irving Leonard | 13.3 | 0 | 1 |
| island reversal | 13.3 | 0 | 1 |
| Dina Powell | 13.3 | 0 | 1 |
| Sciforma PSNext | 13.3 | 0 | 1 |
| Swiss Mutual Fund | 13.3 | 0 | 1 |
| climate risk | 13.3 | 0 | 1 |
| ISO/IEC 38500 | 13.3 | 0 | 1 |
| Banca Generali Private | 13.3 | 0 | 1 |
| Bernardino Nogara | 13.3 | 0 | 1 |
| Federal popular initiative "against excessive remunerations" | 13.3 | 0 | 1 |
| environmental, social and corporate governance | 13.3 | 0 | 1 |
| Standard Ethics Aei | 13.3 | 0 | 1 |
| Stefano Paleari | 13.3 | 0 | 1 |
| Harris myCFO | 13.3 | 0 | 1 |
| Ruben Vardanyan | 13.3 | 0 | 1 |
| investment fund | 13.3 | 0 | 1 |
| 130–30 fund | 13.3 | 0 | 1 |
| 2003 mutual fund scandal | 13.3 | 0 | 1 |
| ADEEM Investment and Wealth Management Company | 13.3 | 0 | 1 |
| active management | 13.3 | 0 | 1 |
| Osaic | 13.3 | 0 | 1 |
| Alexandra Armstrong | 13.3 | 0 | 1 |
| Arthur Kade | 13.3 | 0 | 1 |
| BNY Mellon Wealth Management Hockey Humanitarian Award | 13.3 | 0 | 1 |
| BT | 13.3 | 0 | 1 |
| Badla | 13.3 | 0 | 1 |
| Ben Wyatt | 13.3 | 0 | 1 |
| Bessemer Trust | 13.3 | 0 | 1 |
| CIBC Mellon | 13.3 | 0 | 1 |
| CIBC Wealth Management | 13.3 | 0 | 1 |
| CJM Fiscal Management | 13.3 | 0 | 1 |
| Cadbury Report | 13.3 | 0 | 1 |
| Camberford Law | 13.3 | 0 | 1 |
| Chaikin Stock Research | 13.3 | 0 | 1 |
| Cheswold Lane Asset Management | 13.3 | 0 | 1 |
| Child Trust Fund | 13.3 | 0 | 1 |
| climate bond | 13.3 | 0 | 1 |
| climate risk management | 13.3 | 0 | 1 |
| Colonial First State | 13.3 | 0 | 1 |
| Columbia Management Group | 13.3 | 0 | 1 |
| Common Sense on Mutual Funds | 13.3 | 0 | 1 |
| Consultancy House | 13.3 | 0 | 1 |
| Corporate Governance | 13.3 | 0 | 1 |
| Corporate governance in the United Kingdom | 13.3 | 0 | 1 |
| Coverdell Education Savings Account | 13.3 | 0 | 1 |
| Crocus Investment Fund | 13.3 | 0 | 1 |
| Dave Ramsey | 13.3 | 0 | 1 |
| Donato A. Montanaro | 13.3 | 0 | 1 |
| Donor Managed Investment Account | 13.3 | 0 | 1 |
| eco-investing | 13.3 | 0 | 1 |
| Eddie Hobbs | 13.3 | 0 | 1 |
| portfolio | 13.3 | 0 | 1 |
| Edward Whitley | 13.3 | 0 | 1 |
| Evercore Wealth Management | 13.3 | 0 | 1 |
| Exchange coffee house | 13.3 | 0 | 1 |
| Fiduciary Trust Company International | 13.3 | 0 | 1 |
| Financial Advisor to the Chief of Staff | 13.3 | 0 | 1 |
| Financial Reporting Council | 13.3 | 0 | 1 |
| Fiona Balfour | 13.3 | 0 | 1 |
| Fullerton Securities | 13.3 | 0 | 1 |
| Fund platform | 13.3 | 0 | 1 |
| Geopolymer cement | 13.3 | 0 | 1 |
| Green Power Usage Effectiveness | 13.3 | 0 | 1 |
| Helen Nugent | 13.3 | 0 | 1 |
| Hilliard Lyons | 13.3 | 0 | 1 |
| Huljich Wealth Management (NZ) Ltd | 13.3 | 0 | 1 |
| Hull Trading Company | 13.3 | 0 | 1 |
| IBM Rational Focal Point | 13.3 | 0 | 1 |
| IGM Financial | 13.3 | 0 | 1 |
| IT portfolio management | 13.3 | 0 | 1 |
| IberoAmerican Federation of Mutual Funds | 13.3 | 0 | 1 |
| ImClone stock trading case | 13.3 | 0 | 1 |
| individual savings account | 13.3 | 0 | 1 |
| Individual retirement account | 13.3 | 0 | 1 |
| Interfaith Center on Corporate Responsibility | 13.3 | 0 | 1 |
| Investor Network on Climate Risk | 13.3 | 0 | 1 |
| J. B. Hanauer | 13.3 | 0 | 1 |
| John Story | 13.3 | 0 | 1 |
| Lightspeed Financial | 13.3 | 0 | 1 |
| list of European power companies by carbon intensity | 13.3 | 0 | 1 |
| list of US mutual funds by assets under management | 13.3 | 0 | 1 |
| list of countries by corporate governance | 13.3 | 0 | 1 |
| Listia | 13.3 | 0 | 1 |
| Maharan Frozenfar | 13.3 | 0 | 1 |
| Low-carbon fuel standard | 13.3 | 0 | 1 |
| Lucian Bebchuk | 13.3 | 0 | 1 |
| Magellan Fund | 13.3 | 0 | 1 |
| Mattioli Woods | 13.3 | 0 | 1 |
| Modified Dietz method | 13.3 | 0 | 1 |
| Mutual Fund Directors Forum | 13.3 | 0 | 1 |
| Mutual Fund Dealers Association | 13.3 | 0 | 1 |
| Category:Corporate governance | 13.3 | 0 | 1 |
| Organizational project management | 13.3 | 0 | 1 |
| Pulse Impact Investing Management Software | 13.3 | 0 | 1 |
| Pamela Thomas-Graham | 13.3 | 0 | 1 |
| passive management | 13.3 | 0 | 1 |
| Plante Moran | 13.3 | 0 | 1 |
| portfolio manager | 13.3 | 0 | 1 |
| Professional Wealth Management | 13.3 | 0 | 1 |
| Puerto Rico Government Development Bank | 13.3 | 0 | 1 |
| Report of the Company Law Amendment Committee | 13.3 | 0 | 1 |
| Robertson Stephens | 13.3 | 0 | 1 |
| Roth IRA | 13.3 | 0 | 1 |
| Salida Capital | 13.3 | 0 | 1 |
| Saving for Education, Entrepreneurship, and Downpayment | 13.3 | 0 | 1 |
| Shareholder primacy | 13.3 | 0 | 1 |
| Simple Dietz method | 13.3 | 0 | 1 |
| Spear's Wealth Management Survey | 13.3 | 0 | 1 |
| Special memorandum account | 13.3 | 0 | 1 |
| St. James's Place Wealth Management Group | 13.3 | 0 | 1 |
| Sustainable investment rule | 13.3 | 0 | 1 |
| The Carbon Principles | 13.3 | 0 | 1 |
| The Journal of Portfolio Management | 13.3 | 0 | 1 |
| The Journal of Wealth Management | 13.3 | 0 | 1 |
| The Samuel and Ronnie Heyman Center on Corporate Governance | 13.3 | 0 | 1 |
| Thomas Forester | 13.3 | 0 | 1 |
| Trading account assets | 13.3 | 0 | 1 |
| Trusts & Estates | 13.3 | 0 | 1 |
| UK Corporate Governance Code | 13.3 | 0 | 1 |
| US SIF | 13.3 | 0 | 1 |
| Unified managed account | 13.3 | 0 | 1 |
| Van Kampen Investments | 13.3 | 0 | 1 |
| Virtual Brokers | 13.3 | 0 | 1 |
| Wellington Fund | 13.3 | 0 | 1 |
| Wes Moss | 13.3 | 0 | 1 |
| World Scientists' Warning to Humanity | 13.3 | 0 | 1 |
| Zero-load | 13.3 | 0 | 1 |
| Creand | 13.3 | 0 | 1 |
| Category:Corporate governance in the United Kingdom | 13.3 | 0 | 1 |
| Category:Mutual fund companies of Canada | 13.3 | 0 | 1 |
| Category:Mutual funds of India | 13.3 | 0 | 1 |
| Category:Online brokerages | 13.3 | 0 | 1 |
| Category:Stock trading films | 13.3 | 0 | 1 |
| Category:Stock trading television shows | 13.3 | 0 | 1 |
| Category:Socially responsible investing | 13.3 | 0 | 1 |
| Category:Stock trading | 13.3 | 0 | 1 |
| Banco Carregosa | 13.3 | 0 | 1 |
| Category:Financial Advisor to the Chief of Staff | 13.3 | 0 | 1 |
| Stock Index with Differentiated Corporate Governance | 13.3 | 0 | 1 |
| IronFX | 13.3 | 0 | 1 |
| Industrial Alliance | 13.3 | 0 | 1 |
| Mutual funds in India | 13.3 | 0 | 1 |
| Mizuho Private Wealth Management | 13.3 | 0 | 1 |
| Wealth Management | 13.3 | 0 | 1 |
| Robert Monks Professor of Corporate Governance | 13.3 | 0 | 1 |
| Formue | 13.3 | 0 | 1 |
| Xact bear | 13.3 | 0 | 1 |
| Trigon Wealth Management | 13.3 | 0 | 1 |
| Florin Georgescu | 13.3 | 0 | 1 |
| Separately managed account | 13.3 | 0 | 1 |
| Gluskin Sheff | 13.3 | 0 | 1 |
| Category:Mutual funds of the United States | 13.3 | 0 | 1 |
| investment management | 13.3 | 0 | 1 |
| wealth management | 13.3 | 0 | 1 |
| Break-even | 13.3 | 0 | 1 |
| Peter Pruzan | 13.3 | 0 | 1 |
| John Neff | 13.3 | 0 | 1 |
| Corporate Governance eJournal | 13.3 | 0 | 1 |
| Corporate Governance International | 13.3 | 0 | 1 |
| Corporate Governance | 13.3 | 0 | 1 |
| International Journal of Corporate Governance | 13.3 | 0 | 1 |
| The Corporate Governance Law Review | 13.3 | 0 | 1 |
| Journal of Project, Program and Portfolio Management | 13.3 | 0 | 1 |
| Journal of Accounting and Corporate Governance | 13.3 | 0 | 1 |
| Werner Baumann | 13.3 | 0 | 1 |
| portfolio management | 13.3 | 0 | 1 |
| Investment controlling | 13.3 | 0 | 1 |
| Michael Kitces | 13.3 | 0 | 1 |
| Integrated financial advisor | 13.3 | 0 | 1 |
| Carhart four-factor model | 13.3 | 0 | 1 |
| Black Creek Investment Management Inc. | 13.3 | 0 | 1 |
| Association of Mutual Funds in India | 13.3 | 0 | 1 |
| efficient frontier | 13.3 | 0 | 1 |
| Addepar | 13.3 | 0 | 1 |
| OurCrowd | 13.3 | 0 | 1 |
| Fundrise | 13.3 | 0 | 1 |
| King Report on Corporate Governance | 13.3 | 0 | 1 |
| Price return | 13.3 | 0 | 1 |
| Island ECN Ltd, The | 13.3 | 0 | 1 |
| impact investing | 13.3 | 0 | 1 |
| Mutual fund separation theorem | 13.3 | 0 | 1 |
| Mutual fund trust | 13.3 | 0 | 1 |
| Resampled efficient frontier | 13.3 | 0 | 1 |
| Worth | 13.3 | 0 | 1 |
| Gaston Browne | 13.3 | 0 | 1 |
| Wealth management product | 13.3 | 0 | 1 |
| U.S. warns of al Qaeda threat to stock trading and banking websites | 13.3 | 0 | 1 |
| Stock exchange merger could end San Francisco stock trading | 13.3 | 0 | 1 |
| Erica Smyth | 13.3 | 0 | 1 |
| Junction | 13.3 | 0 | 1 |
| Computer Age Management Services Pvt Ltd | 13.3 | 0 | 1 |
| Fidelity Magellan | 13.3 | 0 | 1 |
| Fidelity Contrafund | 13.3 | 0 | 1 |
| Product Portfolio Management | 13.3 | 0 | 1 |
| Integral Forex | 13.3 | 0 | 1 |
| Kraft Heinz | 13.3 | 0 | 1 |
| Securities and Exchange Board Of India (Mutual Funds) Regulations, 1996 | 13.3 | 0 | 1 |
| fossil-fuel divestment | 13.3 | 0 | 1 |
| Global Impact Investing Network | 13.3 | 0 | 1 |
| Agriculture and Climate Risk Enterprise Ltd. | 13.3 | 0 | 1 |
| Greg N. Gregoriou | 13.3 | 0 | 1 |
| The Illogicality of Stock-Brokers: Psychological Experiments on the Effects of Prior Knowledge and Belief Biases on Logical Reasoning in Stock Trading | 13.3 | 0 | 1 |
| Susanne Lütz | 13.3 | 0 | 1 |
| Template:Mutual fund | 13.3 | 0 | 1 |
| Kawase (company) | 13.3 | 0 | 1 |
| ICICI Prudential Mutual Fund | 13.3 | 0 | 1 |
| Islamic Reporting Initiative | 13.3 | 0 | 1 |
| Roobee | 13.3 | 0 | 1 |
| Chris McKnett | 13.3 | 0 | 1 |
| Andrew Kuper | 13.3 | 0 | 1 |
| Consequences of False-Positive Screening Mammograms | 13.3 | 0 | 1 |
| Contributions to accelerating atmospheric CO2 growth from economic activity, carbon intensity, and efficiency of natural sinks | 13.3 | 0 | 1 |
| Indian Journal of Corporate Governance | 13.3 | 0 | 1 |
| SBI Mutual Fund | 13.3 | 0 | 1 |
| One share, one vote | 13.3 | 0 | 1 |
| Home Development Mutual Fund | 13.3 | 0 | 1 |
| enterprise service management | 13.3 | 0 | 1 |
| Portfolio Management Professional | 13.3 | 0 | 1 |
| Don Brownstein | 13.3 | 0 | 1 |
| Structured Portfolio Management | 13.3 | 0 | 1 |
| Health impact metrics for air pollution management strategies | 13.3 | 0 | 1 |
| K2 | 13.3 | 0 | 1 |
| Q26829085 | 13.3 | 0 | 1 |
| ecohouse | 13.3 | 0 | 1 |
| Delaware Management Business Trust | 13.3 | 0 | 1 |
| Emma Sophia Galton | 13.3 | 0 | 1 |
| IC Markets | 13.3 | 0 | 1 |
| Australian Local Government Fossil Fuel Divestment | 13.3 | 0 | 1 |
| Managing Climate Risk | 13.3 | 0 | 1 |
| Blunt abdominal trauma: clinical value of negative screening US scans | 13.3 | 0 | 1 |
| A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency | 13.3 | 0 | 1 |
| Gastric cancer after positive screening faecal occult blood testing and negative assessment | 13.3 | 0 | 1 |
| In vitro evaluation of some derivatives of the carcinogen butter yellow: implications for environmental screening | 13.3 | 0 | 1 |
| Ken Kwaku | 13.3 | 0 | 1 |
| Hugh Shine | 13.3 | 0 | 1 |
| Category:Corporate governance in India | 13.3 | 0 | 1 |
| Hydropower's Biogenic Carbon Footprint | 13.3 | 0 | 1 |
| Comparison of the environmental footprint of the egg industry in the United States in 1960 and 2010 | 13.3 | 0 | 1 |
| Effect of technology innovation and spillovers on the carbon intensity of human well-being | 13.3 | 0 | 1 |
| Corporate governance and business ethics | 13.3 | 0 | 1 |
| A Greenhouse Gas and Soil Carbon Model for Estimating the Carbon Footprint of Livestock Production in Canada | 13.3 | 0 | 1 |
| The changing effect of economic development on the consumption-based carbon intensity of well-being, 1990-2008. | 13.3 | 0 | 1 |
| Improving farming practices reduces the carbon footprint of spring wheat production | 13.3 | 0 | 1 |
| Putting Your Money Where Your Mouth Is: Why Sustainability Reporting Based on the Triple Bottom Line Can Be Misleading | 13.3 | 0 | 1 |
| Greenhouse gas emissions of realistic dietary choices in Denmark: the carbon footprint and nutritional value of dairy products | 13.3 | 0 | 1 |
| Nippon Individual Savings Account | 13.3 | 0 | 1 |
| Green and Good? The Investment Performance of US Environmental Mutual Funds | 13.3 | 0 | 1 |
| The carbon footprint of biofuels: can we shrink it down to size in time? | 13.3 | 0 | 1 |
| Environmental Screening for the Scedosporium apiospermum Species Complex in Public Parks in Bangkok, Thailand | 13.3 | 0 | 1 |
| An investigation into the relation between corporate governance and firm value in the U.K | 13.3 | 0 | 1 |
| Diamonds vs. precious metals: What shines brightest in your investment portfolio? | 13.3 | 0 | 1 |
| OPTIMAL PORTFOLIO MANAGEMENT WITH FIXED TRANSACTION COSTS | 13.3 | 0 | 1 |
| Anjan V. Thakor | 13.3 | 0 | 1 |
| The U.S. government's medical countermeasure portfolio management for nuclear and radiological emergencies: synergy from interagency cooperation | 13.3 | 0 | 1 |
| Norwegian Corporate Governance Board | 13.3 | 0 | 1 |
| Climate Risk Analysis (Germany) | 13.3 | 0 | 1 |
| Prevalence of positive screening test for cognitive impairment among elderly urogynecologic patients | 13.3 | 0 | 1 |
| Oxfam America | 13.3 | 0 | 1 |
| What can we learn from corporate sustainability reporting? Deriving propositions for research and practice from over 9,500 corporate sustainability reports published between 1999 and 2015 using topic modelling technique | 13.3 | 0 | 1 |
| Community diversity, structure and carbon footprint of nematode food web following reforestation on degraded Karst soil. | 13.3 | 0 | 1 |
| Effects of Warming on CO2 Fluxes in an Alpine Meadow Ecosystem on the Central Qinghai–Tibetan Plateau | 13.3 | 0 | 1 |
| The old care paradigm is dead, long live the new sustainable care paradigm: how can GP commissioning consortia meet the demand challenges of 21st century healthcare? | 13.3 | 0 | 1 |
| A Real-Time Recording Model of Key Indicators for Energy Consumption and Carbon Emissions of Sustainable Buildings | 13.3 | 0 | 1 |
| Process orientation as a tool of strategic approaches to corporate governance and integrated management systems | 13.3 | 0 | 1 |
| Reducing the environmental impact of trials: a comparison of the carbon footprint of the CRASH-1 and CRASH-2 clinical trials | 13.3 | 0 | 1 |
| Optimal expansion of a drinking water infrastructure system with respect to carbon footprint, cost-effectiveness and water demand | 13.3 | 0 | 1 |
| Quantifying Carbon Footprint Reduction Opportunities for U.S. Households and Communities | 13.3 | 0 | 1 |
| Cost of breast-related care in the year following false positive screening mammograms | 13.3 | 0 | 1 |
| The carbon footprint of cataract surgery | 13.3 | 0 | 1 |
| Category:Corporate governance in the United States | 13.3 | 0 | 1 |
| Category:Corporate governance in Australia | 13.3 | 0 | 1 |
| The Carbon Footprint of Conference Papers | 13.3 | 0 | 1 |
| The environmental sustainability of microalgae as feed for aquaculture: A life cycle perspective | 13.3 | 0 | 1 |
| The social consequences of conspiracism: Exposure to conspiracy theories decreases intentions to engage in politics and to reduce one's carbon footprint. | 13.3 | 0 | 1 |
| The greenhouse emissions footprint of free-range eggs | 13.3 | 0 | 1 |
| Research developments in methods to reduce the carbon footprint of the food system: a review | 13.3 | 0 | 1 |
| A method for calculating a land-use change carbon footprint (LUC-CFP) for agricultural commodities - applications to Brazilian beef and soy, Indonesian palm oil. | 13.3 | 0 | 1 |
| Sustainability of meat production beyond carbon footprint: a synthesis of case studies from grazing systems in Uruguay | 13.3 | 0 | 1 |
| The carbon footprint of acute care: how energy intensive is critical care? | 13.3 | 0 | 1 |
| Comparison of the carbon footprint of different patient diets in a Spanish hospital | 13.3 | 0 | 1 |
| Improved Climate Risk Simulations for Rice in Arid Environments | 13.3 | 0 | 1 |
| Environmental screening of acidic compounds based on capillary zone electrophoresis/laser-induced fluorescence detection with identification by gas chromatography/mass spectrometry and gas chromatography/high-resolution mass spectrometry | 13.3 | 0 | 1 |
| Primary-care-based social prescribing for mental health: an analysis of financial and environmental sustainability | 13.3 | 0 | 1 |
| Relating the carbon footprint of milk from Irish dairy farms to economic performance | 13.3 | 0 | 1 |
| Environment and economic risk: An analysis of carbon emission market and portfolio management | 13.3 | 0 | 1 |
| Shop locally for food to help reduce your carbon footprint | 13.3 | 0 | 1 |
| How scientists can reduce their carbon footprint | 13.3 | 0 | 1 |
| Carbon footprint in five third-level health care centers in Peru, 2013 | 13.3 | 0 | 1 |
| Product vs corporate carbon footprint: Some methodological issues. A case study and review on the wine sector. | 13.3 | 0 | 1 |
| A simple comparison of mass spectral search results and implications for environmental screening analyses | 13.3 | 0 | 1 |
| The importance of carbon footprint estimation boundaries | 13.3 | 0 | 1 |
| Cooperative water network system to reduce carbon footprint | 13.3 | 0 | 1 |
| Positive screening on the Modified Checklist for Autism in Toddlers (M-CHAT) in extremely low gestational age newborns | 13.3 | 0 | 1 |
| Beyond Naphthenic Acids: Environmental Screening of Water from Natural Sources and the Athabasca Oil Sands Industry Using Atmospheric Pressure Photoionization Fourier Transform Ion Cyclotron Resonance Mass Spectrometry | 13.3 | 0 | 1 |
| Translation and validation study of the Persian version of the Arthritis Impact Measurement Scales 2 (AIMS2) in patients with osteoarthritis of the knee. | 13.3 | 0 | 1 |
| Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen | 13.3 | 0 | 1 |
| Climate risk information: climate change scenarios and implications for NYC infrastructure. New York City Panel on Climate Change | 13.3 | 0 | 1 |
| Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy | 13.3 | 0 | 1 |
| The carbon footprint of a renal service in the United Kingdom | 13.3 | 0 | 1 |
| Carbon footprint: current methods of estimation | 13.3 | 0 | 1 |
| Modelling the carbon footprint of reflux control | 13.3 | 0 | 1 |
| Kroppenstedtia eburnea gen. nov., sp. nov., a thermoactinomycete isolated by environmental screening, and emended description of the family Thermoactinomycetaceae Matsuo et al. 2006 emend. Yassin et al. 2009. | 13.3 | 0 | 1 |
| Seasonal and geographical distribution of bacillary dysentery (shigellosis) and associated climate risk factors in Kon Tam Province in Vietnam from 1999 to 2013. | 13.3 | 0 | 1 |
| Carbon footprint of grain production in China | 13.3 | 0 | 1 |
| Role of Fuel Carbon Intensity in Achieving 2050 Greenhouse Gas Reduction Goals within the Light-Duty Vehicle Sector | 13.3 | 0 | 1 |
| Why Does the Law of One Price Fail? An Experiment on Index Mutual Funds | 13.3 | 0 | 1 |
| Modelling the cumulative risk of a false-positive screening test. | 13.3 | 0 | 1 |
| Carbon footprint of telemedicine solutions--unexplored opportunity for reducing carbon emissions in the health sector | 13.3 | 0 | 1 |
| Limitations of Carbon Footprint as Indicator of Environmental Sustainability | 13.3 | 0 | 1 |
| How does Medicaid-managed care impact reporting of Medicaid status? | 13.3 | 0 | 1 |
| CT colonography with limited bowel preparation for the detection of colorectal neoplasia in an FOBT positive screening population | 13.3 | 0 | 1 |
| Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by ethnicity and area for 2005-07 | 13.3 | 0 | 1 |
| Ed Butowsky | 13.3 | 0 | 1 |
| Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. | 13.3 | 0 | 1 |
| What’s the difference between a hedge fund and a mutual fund? | 13.3 | 0 | 1 |
| Risk of Upper Gastrointestinal Cancers in Patients With Gastroesophageal Reflux Disease After a Negative Screening Endoscopy | 13.3 | 0 | 1 |
| Five-year risk of colorectal neoplasia after negative screening colonoscopy | 13.3 | 0 | 1 |
| Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice | 13.3 | 0 | 1 |
| Making the most of common impact metrics: promising approaches that need further study | 13.3 | 0 | 1 |
| Functional environmental screening of a metagenomic library identifies stlA; a unique salt tolerance locus from the human gut microbiome. | 13.3 | 0 | 1 |
| False negative screening tests in phenylketonuria | 13.3 | 0 | 1 |
| Reproducibility and responsiveness of the Symptom Severity Scale and the hand and finger function subscale of the Dutch arthritis impact measurement scales (Dutch-AIMS2-HFF) in primary care patients with wrist or hand problems | 13.3 | 0 | 1 |
| Combining XCO2 Measurements Derived from SCIAMACHY and GOSAT for Potentially Generating Global CO2 Maps with High Spatiotemporal Resolution | 13.3 | 0 | 1 |
| Integration of ecosystem services into the carbon footprint of milk of South German dairy farms | 13.3 | 0 | 1 |
| Screening for a gene deletion mutant whose temperature sensitivity is suppressed by FK506 in budding yeast and its application for a positive screening for drugs inhibiting calcineurin. | 13.3 | 0 | 1 |
| Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review. | 13.3 | 0 | 1 |
| Working toward Healthy and Sustainable Diets: The “Double Pyramid Model” Developed by the Barilla Center for Food and Nutrition to Raise Awareness about the Environmental and Nutritional Impact of Foods | 13.3 | 0 | 1 |
| The adequacy of measurement of short and long-term consequences of false-positive screening mammography | 13.3 | 0 | 1 |
| The need for sustainable psychiatry | 13.3 | 0 | 1 |
| Does a negative screening colonoscopy ever need to be repeated? | 13.3 | 0 | 1 |
| Who should manage your investment portfolio? | 13.3 | 0 | 1 |
| Carbon footprint and cost-effectiveness of cataract surgery. | 13.3 | 0 | 1 |
| Perception of Climate Risk among Rural Farmers in Vietnam: Consistency within Households and with the Empirical Record | 13.3 | 0 | 1 |
| The Geometric Phase of Stock Trading. | 13.3 | 0 | 1 |
| Climate Risk Modelling of Balsam Woolly Adelgid Damage Severity in Subalpine Fir Stands of Western North America | 13.3 | 0 | 1 |
| Building a Values-Informed Mental Model for New Orleans Climate Risk Management | 13.3 | 0 | 1 |
| Measuring scientific impact beyond academia: An assessment of existing impact metrics and proposed improvements. | 13.3 | 0 | 1 |
| Joint carbon footprint assessment and data envelopment analysis for the reduction of greenhouse gas emissions in agriculture production. | 13.3 | 0 | 1 |
| Inventory analysis and carbon footprint of coastland-hotel services: A Spanish case study | 13.3 | 0 | 1 |
| Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram | 13.3 | 0 | 1 |
| Determination of the carbon footprint of all Galician production and consumption activities: Lessons learnt and guidelines for policymakers | 13.3 | 0 | 1 |
| Breast cancer risk for women with a false positive screening test | 13.3 | 0 | 1 |
| Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use. | 13.3 | 0 | 1 |
| Low risk of cervical cancer during a long period after negative screening in the Netherlands | 13.3 | 0 | 1 |
| Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards. | 13.3 | 0 | 1 |
| Long-Term Psychosocial Consequences of False-Positive Screening Mammography | 13.3 | 0 | 1 |
| A Semiparametric Censoring Bias Model for Estimating the Cumulative Risk of a False‐Positive Screening Test Under Dependent Censoring | 13.3 | 0 | 1 |
| Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results? | 13.3 | 0 | 1 |
| Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia | 13.3 | 0 | 1 |
| Carbon footprint of patient journeys through primary care: a mixed methods approach | 13.3 | 0 | 1 |
| Head Impact Measurement Devices | 13.3 | 0 | 1 |
| Re-attendance after false-positive screening mammography: a population-based study in the Netherlands. | 13.3 | 0 | 1 |
| Enacting corporate governance of healthcare safety and quality: a dramaturgy of hospital boards in England | 13.3 | 0 | 1 |
| Positive screening for autism in ex-preterm infants: prevalence and risk factors | 13.3 | 0 | 1 |
| Gene expression profile of whole blood cells differs in pregnant women with positive screening and negative diagnosis for gestational diabetes. | 13.3 | 0 | 1 |
| Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer | 13.3 | 0 | 1 |
| Assessing the evolution of sustainability reporting in the mining sector | 13.3 | 0 | 1 |
| The ACS investment portfolio: a review and update | 13.3 | 0 | 1 |
| Portfolio management in early stage drug discovery – a traveler's guide through uncharted territory | 13.3 | 0 | 1 |
| Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic | 13.3 | 0 | 1 |
| Colon cancer screening. The dilemma of positive screening tests | 13.3 | 0 | 1 |
| Life cycle carbon footprint of shale gas: review of evidence and implications. | 13.3 | 0 | 1 |
| Psychological consequences of false-positive screening mammograms in the UK. | 13.3 | 0 | 1 |
| Systematic review of the psychological consequences of false-positive screening mammograms | 13.3 | 0 | 1 |
| The impact of pharmacovigilance on drug portfolio management | 13.3 | 0 | 1 |
| Disaster risk insurance and catastrophe models in risk‐prone small Caribbean islands | 13.3 | 0 | 1 |
| Carbon footprint of robotically‐assisted laparoscopy, laparoscopy and laparotomy: a comparison | 13.3 | 0 | 1 |
| Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland | 13.3 | 0 | 1 |
| Sustainability reporting in public sector organisations: Exploring the relation between the reporting process and organisational change management for sustainability | 13.3 | 0 | 1 |
| A review of corporate sustainability reporting tools (SRTs) | 13.3 | 0 | 1 |
| Evaluation of allocation methods for calculation of carbon footprint of grass-based dairy production | 13.3 | 0 | 1 |
| Water footprint and carbon footprint of the energy consumption in sunflower agroecosystems | 13.3 | 0 | 1 |
| Carbon footprint as an environmental sustainability indicator for the particleboard produced in Pakistan | 13.3 | 0 | 1 |
| Spatial Optimization of Future Urban Development with Regards to Climate Risk and Sustainability Objectives. | 13.3 | 0 | 1 |
| Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis | 13.3 | 0 | 1 |
| Producing HIV estimates: from global advocacy to country planning and impact measurement | 13.3 | 0 | 1 |
| Does diet intervention in line with nutrition recommendations affect dietary carbon footprint? Results from a weight loss trial among lactating women. | 13.3 | 0 | 1 |
| Carbon footprint as an instrument for enhancing food quality: overview of the wine, olive oil and cereals sectors | 13.3 | 0 | 1 |
| Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test | 13.3 | 0 | 1 |
| A carbon footprint simulation model for the cork oak sector | 13.3 | 0 | 1 |
| The carbon footprint of Australian ambulance operations | 13.3 | 0 | 1 |
| Prevalence and predictors of positive screening for postpartum depression in minority parturients in the South Bronx. | 13.3 | 0 | 1 |
| Carbon footprint of premium quality export bananas: case study in Ecuador, the world's largest exporter | 13.3 | 0 | 1 |
| Hurricane Katrina's carbon footprint on U.S. Gulf Coast forests | 13.3 | 0 | 1 |
| Understanding Traditional Research Impact Metrics | 13.3 | 0 | 1 |
| A crisis of visibility: The psychological consequences of false-positive screening mammograms, an interview study | 13.3 | 0 | 1 |
| Changes in the carbon footprint of Japanese households in an aging society | 13.3 | 0 | 1 |
| The Evolution of Current Research Impact Metrics: From Bibliometrics to Altmetrics? | 13.3 | 0 | 1 |
| Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography | 13.3 | 0 | 1 |
| Donors' psychological reactions to deferral following false‐positive screening test results | 13.3 | 0 | 1 |
| Affective temperaments and emotional traits are associated with a positive screening for premenstrual dysphoric disorder | 13.3 | 0 | 1 |
| Diarrhea outbreaks in northeastern Brazil in 2013, according to media and health information systems - Surveillance of climate risk and health emergencies | 13.3 | 0 | 1 |
| Women with false positive screening mammograms: how do they cope? | 13.3 | 0 | 1 |
| Identifying energy and carbon footprint optimization potentials of a sludge treatment line with Life Cycle Assessment | 13.3 | 0 | 1 |
| Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort | 13.3 | 0 | 1 |
| Bypassing antibiotic selection: positive screening of genetically modified cells with an antigen-dependent proliferation switch | 13.3 | 0 | 1 |
| Green campaigners urge staff to set example by cutting carbon footprint | 13.3 | 0 | 1 |
| Malignant Transformation in Vitro: Criteria, Biological Markers, and Application in Environmental Screening of Carcinogens | 13.3 | 0 | 1 |
| Aircraft-based measurements of the carbon footprint of Indianapolis | 13.3 | 0 | 1 |
| Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism | 13.3 | 0 | 1 |
| Cultural adaptation and validation of the Persian version of the Arthritis Impact Measurement Scales 2-Short Form in patients with osteoarthritis of the knee | 13.3 | 0 | 1 |
| Translation and validation of the Persian version of the Arthritis Impact Measurement Scales 2-Short Form (AIMS2-SF) in patients with rheumatoid arthritis. | 13.3 | 0 | 1 |
| The future of public hospitals in a globalized world: corporate governance, corporatization or privatization? | 13.3 | 0 | 1 |
| Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test | 13.3 | 0 | 1 |
| Alcohol use and positive screening results for depression and anxiety are highly prevalent among Chinese children with strabismus | 13.3 | 0 | 1 |
| Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results | 13.3 | 0 | 1 |
| Harvard Law School Forum on Corporate Governance and Financial Regulation | 13.3 | 0 | 1 |
| Lack of Association Between The 5-HTTLPR and Positive Screening for Mental Disorders Among Children Exposed to Urban Violence and Maltreatment | 13.3 | 0 | 1 |
| Stock trading using RSPOP: a novel rough set-based neuro-fuzzy approach. | 13.3 | 0 | 1 |
| Validation of the Chinese version of the diabetes impact measurement scales amongst people suffering from diabetes | 13.3 | 0 | 1 |
| The Vaccine Portfolio Management Model as an Efficiency Tool for Japan | 13.3 | 0 | 1 |
| Positive screening and risk factors for postpartum depression | 13.3 | 0 | 1 |
| Colon pathology detected after a positive screening flexible sigmoidoscopy: a prospective study in an ethnically diverse cohort | 13.3 | 0 | 1 |
| Special mutual funds and investment services | 13.3 | 0 | 1 |
| Measuring Urban Carbon Footprint from Carbon Flows in the Global Supply Chain | 13.3 | 0 | 1 |
| Productivity and carbon footprint of perennial grass-forage legume intercropping strategies with high or low nitrogen fertilizer input | 13.3 | 0 | 1 |
| Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea. | 13.3 | 0 | 1 |
| Carbon footprint of urban source separation for nutrient recovery | 13.3 | 0 | 1 |
| Technical feasibility and carbon footprint of biochar co-production with tomato plant residue. | 13.3 | 0 | 1 |
| Individual Retirement Account Balances, Contributions, and Rollovers, 2013; With Longitudinal Results 2010-2013: The EBRI IRA Database | 13.3 | 0 | 1 |
| Rectal tuberculosis after infliximab therapy despite negative screening for latent tuberculosis in a patient with ulcerative colitis | 13.3 | 0 | 1 |
| Incidence of invasive cervical cancer preceded by negative screening in high-risk Alaska Native women | 13.3 | 0 | 1 |
| A False-Positive Screening Mammogram Suggests Higher Breast Cancer Risk | 13.3 | 0 | 1 |
| Adaptation of signature-tagged mutagenesis for Toxoplasma gondii: a negative screening strategy to isolate genes that are essential in restrictive growth conditions | 13.3 | 0 | 1 |
| Positive Illusions and Forecasting Errors in Mutual Fund Investment Decisions | 13.3 | 0 | 1 |
| Gerontechnology. A sustainable investment in the future | 13.3 | 0 | 1 |
| Cradle-to-farm gate environmental footprints of beef cattle production in Kansas, Oklahoma, and Texas1 | 13.3 | 0 | 1 |
| Food consumption and waste and the embedded carbon, water and ecological footprints of households in China | 13.3 | 0 | 1 |
| Carbon footprint of dairy goat milk production in New Zealand | 13.3 | 0 | 1 |
| A comparative study on carbon footprint of rice production between household and aggregated farms from Jiangxi, China | 13.3 | 0 | 1 |
| Energy budgeting and carbon footprint of transgenic cotton–wheat production system through peanut intercropping and FYM addition | 13.3 | 0 | 1 |
| Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate | 13.3 | 0 | 1 |
| A Comparison of Carbon Footprint and Production Cost of Different Pasta Products Based on Whole Egg and Pea Flour | 13.3 | 0 | 1 |
| A model of health status for rheumatoid arthritis. a factor analysis of the arthritis impact measurement scales | 13.3 | 0 | 1 |
| Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test | 13.3 | 0 | 1 |
| Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study | 13.3 | 0 | 1 |
| Energy and nutrient density of foods in relation to their carbon footprint. | 13.3 | 0 | 1 |
| Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme. | 13.3 | 0 | 1 |
| COMPARISON OF A HEAD MOUNTED IMPACT MEASUREMENT DEVICE TO THE HYBRID III ANTHROPOMORPHIC TESTING DEVICE IN A CONTROLLED LABORATORY SETTING. | 13.3 | 0 | 1 |
| Evaluation of the Dutch Arthritis Impact Measurement Scales (DUTCH-AIMS) in patients with rheumatoid arthritis | 13.3 | 0 | 1 |
| Limitations of “Validation Study of Helmet-Based Impact Measurement System in Hockey” | 13.3 | 0 | 1 |
| A nonlinear bi-level programming approach for product portfolio management | 13.3 | 0 | 1 |
| Negative screening tests in classical galactosaemia caused by S135L homozygosity. | 13.3 | 0 | 1 |
| Using corporate governance to enhance 'long-term situation awareness' and assist in the avoidance of organisation-induced disasters | 13.3 | 0 | 1 |
| An outbreak of vancomycin-resistant Enterococcus faecium in an acute care pediatric hospital: Lessons from environmental screening and a case-control study | 13.3 | 0 | 1 |
| Quality assurance and impact measurement of university affiliated programs | 13.3 | 0 | 1 |
| Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening | 13.3 | 0 | 1 |
| Incidence of positive screening for obstructive sleep apnea in patients with isolated cleft lip and/or palate | 13.3 | 0 | 1 |
| How to choose the best financial advisor | 13.3 | 0 | 1 |
| Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). | 13.3 | 0 | 1 |
| Identifying influential directors in the United States corporate governance network | 13.3 | 0 | 1 |
| Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005. | 13.3 | 0 | 1 |
| Reducing your carbon footprint: How telemedicine helps | 13.3 | 0 | 1 |
| More calls for ethical investing | 13.3 | 0 | 1 |
| Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. A positive screening test for an untreatable condition provides psychological relief from uncertainty | 13.3 | 0 | 1 |
| John Flint | 13.3 | 0 | 1 |
| Why won't my financial advisor beat the market? Reflections on the ‘Black Swan’ | 13.3 | 0 | 1 |
| False-positive screening results in the Finnish prostate cancer screening trial | 13.3 | 0 | 1 |
| Where do I put my money? Mutual funds versus exchange-traded funds | 13.3 | 0 | 1 |
| Reducing the carbon footprint of medical conferences | 13.3 | 0 | 1 |
| Carbon footprint of patient journeys | 13.3 | 0 | 1 |
| NHS should bring in measures to reduce its carbon footprint, BMA says | 13.3 | 0 | 1 |
| Reducing NHS carbon footprint: Time for a culture change | 13.3 | 0 | 1 |
| British mutual fund sets a good example. | 13.3 | 0 | 1 |
| Role of dairy in the carbon footprint of US beef | 13.3 | 0 | 1 |
| Carbon footprint of aerobic biological treatment of winery wastewater | 13.3 | 0 | 1 |
| Recalibrating the human carbon footprint from wastewater | 13.3 | 0 | 1 |
| Food waste minimization from a life-cycle perspective | 13.3 | 0 | 1 |
| Minimizing N2O emissions and carbon footprint on a full-scale activated sludge sequencing batch reactor | 13.3 | 0 | 1 |
| Recyclability of bottom ash mixed with dredged soils according to the transportation distance and mixing ratio through the estimation of CO2 emissions | 13.3 | 0 | 1 |
| Potential for improving the carbon footprint of butter and blend products | 13.3 | 0 | 1 |
| Life Cycle Assessment and Carbon Footprint in the Wine Supply-Chain | 13.3 | 0 | 1 |
| Impact on carbon footprint: a life cycle assessment of disposable versus reusable sharps containers in a large US hospital | 13.3 | 0 | 1 |
| Monitoring the aeration efficiency and carbon footprint of a medium-sized WWTP: experimental results on oxidation tank and aerobic digester | 13.3 | 0 | 1 |
| Carbon footprint assessment of recycling technologies for rare earth elements: A case study of recycling yttrium and europium from phosphor | 13.3 | 0 | 1 |
| Carbon footprint assessment of Western Australian Groundwater Recycling Scheme | 13.3 | 0 | 1 |
| Carbon footprint and energy use of food waste management options for fresh fruit and vegetables from supermarkets. | 13.3 | 0 | 1 |
| The carbon footprint of an Australian satellite haemodialysis unit | 13.3 | 0 | 1 |
| The green operating room: simple changes to reduce cost and our carbon footprint | 13.3 | 0 | 1 |
| Role of primary sedimentation on plant-wide energy recovery and carbon footprint | 13.3 | 0 | 1 |
| Carbon footprints of Scandinavian wastewater treatment plants | 13.3 | 0 | 1 |
| Assessment of carbon footprint emissions and environmental concerns of solid waste treatment and disposal techniques; case study of Malaysia | 13.3 | 0 | 1 |
| Carbon footprint associated with four disposal scenarios for urban pruning waste. | 13.3 | 0 | 1 |
| What are we BIF-fing about?: science needs impact metrics | 13.3 | 0 | 1 |
| Estimation of the carbon footprint of the Galician fishing activity (NW Spain). | 13.3 | 0 | 1 |
| HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload | 13.3 | 0 | 1 |
| Confirmatory factor analysis of the Arthritis Impact Measurement Scales 2 short form in patients with rheumatoid arthritis | 13.3 | 0 | 1 |
| Including carbon emissions from deforestation in the carbon footprint of Brazilian beef. | 13.3 | 0 | 1 |
| Positive screening tests for barbiturates in urine samples in the York area over a 1-year period | 13.3 | 0 | 1 |
| Getting the most from mutual funds | 13.3 | 0 | 1 |
| Achieving deep cuts in the carbon intensity of U.S. automobile transportation by 2050: complementary roles for electricity and biofuels | 13.3 | 0 | 1 |
| Mutual funds: affordable investing | 13.3 | 0 | 1 |
| The need for vigilance: false-negative screening for adenylosuccinate lyase deficiency caused by deribosylation of urinary biomarkers. | 13.3 | 0 | 1 |
| [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and t | 13.3 | 0 | 1 |
| Avoidable surgical consultations in women with a positive screening mammogram: experience from a southern region of the Dutch breast screening programme | 13.3 | 0 | 1 |
| How the mutual funds scored last year | 13.3 | 0 | 1 |
| Prognosis of patients with positive screening but negative diagnostic test for gestational diabetes | 13.3 | 0 | 1 |
| Evaluation of a Hebrew version of the revised and expanded Arthritis Impact Measurement Scales (AIMS2) in patients with fibromyalgia | 13.3 | 0 | 1 |
| Mutual funds for you? | 13.3 | 0 | 1 |
| Is the Arthritis Impact Measurement Scales 2 a good tool to assess quality of life in Slovak patients with rheumatoid arthritis? | 13.3 | 0 | 1 |
| The nurse and her money. Mutual funds can help provide for retirement | 13.3 | 0 | 1 |
| Carbon footprint and ammonia emissions of California beef production systems1 | 13.3 | 0 | 1 |
| Positive screening for MRSA--clinical consequences? | 13.3 | 0 | 1 |
| The GERI-AIMS. Reliability and validity of the arthritis impact measurement scales adapted for elderly respondents | 13.3 | 0 | 1 |
| Assessment of carbon footprint and energy performance of the extra virgin olive oil chain in Umbria, Italy | 13.3 | 0 | 1 |
| Use of the INNO-LIA syphilis score assay in the resolution of discordant positive screening enzyme immunoassay results for the serological diagnosis of syphilis | 13.3 | 0 | 1 |
| Reducing the Carbon Footprint of the Operating Theatre: A Multicentre Quality Improvement Report | 13.3 | 0 | 1 |
| Cocoa shortfall: Pollination curbs climate risk to cocoa | 13.3 | 0 | 1 |
| Negative screening colonoscopy after a positive guaiac faecal occult blood test: not a contraindication to continued screening. | 13.3 | 0 | 1 |
| Empirical study of the tails of mutual fund size | 13.3 | 0 | 1 |
| Determinants and outcome of unsuccessful referral after positive screening in a large birth-cohort study of population-based vision screening | 13.3 | 0 | 1 |
| Author Impact Metrics in Communication Sciences and Disorder Research. | 13.3 | 0 | 1 |
| False-positive Screening Mammograms and Biopsies Among Women Participating in a Canadian Provincial Breast Screening Program | 13.3 | 0 | 1 |
| After a negative screening colonoscopy, a microsimulation model shows that currently recommended strategies are equally effective for rescreening | 13.3 | 0 | 1 |
| The carbon footprint of pasture-based milk production: Can white clover make a difference? | 13.3 | 0 | 1 |
| A patient with Calvé-Legg-Perthes syndrome, elevated levels of creatine phosphokinase and positive screening for mucopolysaccharides | 13.3 | 0 | 1 |
| Further evidence of false negative screening for lupus anticoagulants | 13.3 | 0 | 1 |
| Self‐reported activity and functioning in daily life; the perspective of persons with haemophilia living in Sweden | 13.3 | 0 | 1 |
| The utility of the Dutch Arthritis Impact Measurement Scales 2 for assessing health status in individuals with haemophilia: a pilot study | 13.3 | 0 | 1 |
| Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia | 13.3 | 0 | 1 |
| Impact of direct greenhouse gas emissions on the carbon footprint of water reclamation processes employing nitrification–denitrification | 13.3 | 0 | 1 |
| Individual retirement account balances, contributions, and rollovers, 2011: the EBRI IRA database | 13.3 | 0 | 1 |
| Identifying climate risk perceptions, information needs, and barriers to information exchange among public land managers | 13.3 | 0 | 1 |
| The carbon footprint of transportation fuels | 13.3 | 0 | 1 |
| The impact of retirement account distributions on measures of family income | 13.3 | 0 | 1 |
| Tracking the editor's carbon footprint | 13.3 | 0 | 1 |
| Carbamazepine and falsely positive screening tests for Cushing's syndrome. | 13.3 | 0 | 1 |
| Measurement of health status in diabetic patients. Diabetes impact measurement scales | 13.3 | 0 | 1 |
| Environmental Screening Effects in 2D Materials: Renormalization of the Bandgap, Electronic Structure, and Optical Spectra of Few-Layer Black Phosphorus | 13.3 | 0 | 1 |
| An environmental screening model to assess the consequences to soil and groundwater from railroad-tank-car spills of light non-aqueous phase liquids. | 13.3 | 0 | 1 |
| Carbon footprint of Canadian dairy products: calculations and issues. | 13.3 | 0 | 1 |
| The carbon footprint of integrated milk production and renewable energy systems - A case study | 13.3 | 0 | 1 |
| Medical Insurance Agency’s investment portfolio: Medical Insurance Agency invests in tobacco industry | 13.3 | 0 | 1 |
| Medical Insurance Agency’s investment portfolio: Medical Insurance Agency’s response | 13.3 | 0 | 1 |
| An assessment of the Arthritis Impact Measurement Scales in 3 ethnic groups | 13.3 | 0 | 1 |
| Estimate of the carbon footprint of the US health care sector | 13.3 | 0 | 1 |
| False-positive screening mammograms: effect of immediate versus later work-up on patient stress | 13.3 | 0 | 1 |
| Are patients with positive screening but negative diagnostic test for gestational diabetes under risk for adverse pregnancy outcome? | 13.3 | 0 | 1 |
| Long-term shifts in life-cycle energy efficiency and carbon intensity. | 13.3 | 0 | 1 |
| Investing in Mutual Funds | 13.3 | 0 | 1 |
| Big dividends. Annual survey of hospital systems shows a strong financial comeback thanks in large part to resurgent investment portfolios. | 13.3 | 0 | 1 |
| Uncovering the Minor Contribution of Land-Cover Change in Upland Forests to the Net Carbon Footprint of a Boreal Hydroelectric Reservoir | 13.3 | 0 | 1 |
| The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. | 13.3 | 0 | 1 |
| A case study of the carbon footprint of milk from high-performing confinement and grass-based dairy farms. | 13.3 | 0 | 1 |
| An extended ASLD trading system to enhance portfolio management | 13.3 | 0 | 1 |
| Carbon footprint of nations: a global, trade-linked analysis | 13.3 | 0 | 1 |
| Economic and environmental assessment of propionic acid production by fermentation using different renewable raw materials | 13.3 | 0 | 1 |
| Rayne de Gruchy | 13.3 | 0 | 1 |
| How do slums change the relationship between urbanization and the carbon intensity of well-being? | 13.3 | 0 | 1 |
| China's Insurance Regulatory Reform, Corporate Governance Behavior and Insurers' Governance Effectiveness | 13.3 | 0 | 1 |
| Climate change mitigation opportunities based on carbon footprint estimates of dietary patterns in Peru | 13.3 | 0 | 1 |
| Translation and validation of Arthritis Impact Measurement Scales 2 into Chinese: CAIMS2. | 13.3 | 0 | 1 |
| Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems | 13.3 | 0 | 1 |
| Time to give due weight to the 'carbon footprint' issue. | 13.3 | 0 | 1 |
| Development and initial validation of a dual-language English-Spanish format for the Arthritis Impact Measurement Scales | 13.3 | 0 | 1 |
| Evaluation of the arthritis impact measurement scales (AIMS2) in Finnish patients with rheumatoid arthritis | 13.3 | 0 | 1 |
| Lightening our carbon footprint: economics, norms and doctors | 13.3 | 0 | 1 |
| Towards usage-based impact metrics: first results from the mesur project | 13.3 | 0 | 1 |
| Irradiated recycled plastic as a concrete additive for improved chemo-mechanical properties and lower carbon footprint | 13.3 | 0 | 1 |
| Changes in carbon footprint when integrating production of filamentous fungi in 1st generation ethanol plants. | 13.3 | 0 | 1 |
| Optimization of Location-Routing Problem for Cold Chain Logistics Considering Carbon Footprint | 13.3 | 0 | 1 |
| A roller coaster of emotions and sense – coping with the perceived psychosocial consequences of a false‐positive screening mammography | 13.3 | 0 | 1 |
| An estimated carbon footprint of NHS primary dental care within England. How can dentistry be more environmentally sustainable? | 13.3 | 0 | 1 |
| Antiphospholipid antibodies are associated with positive screening for common mental disorders in women with previous pregnancy loss. The NOHA-PSY observational study. | 13.3 | 0 | 1 |
| Health status in rheumatoid arthritis: cross cultural evaluation of a Portuguese version of the Arthritis Impact Measurement Scales 2 (BRASIL-AIMS2) | 13.3 | 0 | 1 |
| Cultural adaptation and validation of a German version of the Arthritis Impact Measurement Scales (AIMS2). | 13.3 | 0 | 1 |
| Towards a new paradigm: Activity level balanced sustainability reporting | 13.3 | 0 | 1 |
| Pharmaceutical Portfolio Management: Global Disease Burden and Corporate Performance Metrics | 13.3 | 0 | 1 |
| Effects of correlations and fees in random multiplicative environments: Implications for portfolio management | 13.3 | 0 | 1 |
| Do negative screening test results cause false reassurance? A systematic review. | 13.3 | 0 | 1 |
| Coupling life-cycle assessment and the RothC model to estimate the carbon footprint of green manure-based wheat production in China | 13.3 | 0 | 1 |
| Some more evidence of long-term psychosocial harms from receiving false-positive screening mammography results | 13.3 | 0 | 1 |
| Variation in carbon footprint of milk due to management differences between Swedish dairy farms | 13.3 | 0 | 1 |
| E-learning in medical education: the potential environmental impact | 13.3 | 0 | 1 |
| Sixty seconds on . . . greening the NHS | 13.3 | 0 | 1 |
| Correspondence: Anaesthesia, the environment, and our carbon footprint | 13.3 | 0 | 1 |
| Are the harms of false-positive screening test results minimal or meaningful? | 13.3 | 0 | 1 |
| Wound healing university diplomas in France: an impact measurement after 6 years | 13.3 | 0 | 1 |
| A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring | 13.3 | 0 | 1 |
| The Glaxo Award: is the American Public Health Association moving toward corporate governance? | 13.3 | 0 | 1 |
| The carbon footprint of dairy production systems through partial life cycle assessment | 13.3 | 0 | 1 |
| Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab | 13.3 | 0 | 1 |
| Carbon footprint in flexible ureteroscopy: A comparative study on the environmental impact of reusable and single-use ureteroscopes | 13.3 | 0 | 1 |
| An interim analysis from Dr Brennan's investment portfolio | 13.3 | 0 | 1 |
| Decreasing attrition rates across the generations through values alignment | 13.3 | 0 | 1 |
| Nicolas de Nobili | 13.3 | 0 | 1 |
| The psychological impact of a false-positive screening mammogram in Barcelona. | 13.3 | 0 | 1 |
| Planetary Stock Trading | 13.3 | 0 | 1 |
| Q48754895 | 13.3 | 0 | 1 |
| OpenUP | 13.3 | 0 | 1 |
| CEE Bankwatch Network | 13.3 | 0 | 1 |
| Mutual fund Q&A. Health care: the sector that just keeps on booming | 13.3 | 0 | 1 |
| Africa50 | 13.3 | 0 | 1 |
| Socially responsible investing is no "sell out". | 13.3 | 0 | 1 |
| Re: Prevalence of Positive Screening Test for Cognitive Impairment among Elderly Urogynecologic Patients | 13.3 | 0 | 1 |
| Individual Retirement Account Balances, Contributions, Withdrawals, and Asset Allocation Longitudinal Results 2010–2014: The EBRI IRA Database | 13.3 | 0 | 1 |
| Carbon footprint of China's belt and road | 13.3 | 0 | 1 |
| Research on the influencing factors of reverse logistics carbon footprint under sustainable development | 13.3 | 0 | 1 |
| Bitcoin's alarming carbon footprint | 13.3 | 0 | 1 |
| Scientifically assess impacts of sustainable investments | 13.3 | 0 | 1 |
| Assessing potential impacts of phosphate precipitation on nitrous oxide emissions and the carbon footprint of wastewater treatment plants. | 13.3 | 0 | 1 |
| Corrigendum to "Productivity and carbon footprint of perennial grass-forage legume intercropping strategies with high or low nitrogen fertilizer input" [Sci. Total Environ. 541 (January 2016) pages 1339-1347]. | 13.3 | 0 | 1 |
| Consumer preferences for food labels on tomatoes in Germany – A comparison of a quasi-experiment and two stated preference approaches | 13.3 | 0 | 1 |
| From the microscope to the macroscopic: changing from the bench to portfolio management | 13.3 | 0 | 1 |
| Positive screening results for autism in ex-preterm infants | 13.3 | 0 | 1 |
| Positive screening results on the modified checklist for autism in toddlers: implications for very preterm populations | 13.3 | 0 | 1 |
| Trusts face green targets in bid to cut carbon footprint. | 13.3 | 0 | 1 |
| Managing corporate governance risks in a nonprofit health care organization | 13.3 | 0 | 1 |
| Climate Risk Management | 13.3 | 0 | 1 |
| Carbon footprint of breton pâté production: A case study | 13.3 | 0 | 1 |
| Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study | 13.3 | 0 | 1 |
| The effect of simple nitrogen fertilizer recommendation strategies on product carbon footprint and gross margin of wheat and maize production in the North China Plain | 13.3 | 0 | 1 |
| Reducing patient anxiety about positive screening tests. | 13.3 | 0 | 1 |
| The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group | 13.3 | 0 | 1 |
| Results of surgical correction of kyphotic deformities of the spine in ankylosing spondylitis on the basis of the modified arthritis impact measurement scales. | 13.3 | 0 | 1 |
| Reducing the carbon footprint of Canadian peat extraction and restoration. | 13.3 | 0 | 1 |
| The arthritis impact measurement scales: an anglicized version to assess the outcome of British patients with rheumatoid arthritis | 13.3 | 0 | 1 |
| Evidence of the validity of the Arthritis Impact Measurement Scales | 13.3 | 0 | 1 |
| Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism | 13.3 | 0 | 1 |
| Differential Responses of Net Ecosystem Exchange of Carbon Dioxide to Light and Temperature between Spring and Neap Tides in Subtropical Mangrove Forests | 13.3 | 0 | 1 |
| Carbon footprint and land requirement for dairy herd rations: impacts of feed production practices and regional climate variations | 13.3 | 0 | 1 |
| Measuring health status in arthritis. The arthritis impact measurement scales | 13.3 | 0 | 1 |
| Gestational and neonatal outcomes in women with positive screening for diabetes mellitus and 100g oral glucose challenge test normal | 13.3 | 0 | 1 |
| Can quick first step bio-psycho-social screening, COMPRI (COMplexity PRediction Instrument), predict length of hospital stay in a general hospital in Japan? | 13.3 | 0 | 1 |
| Polylactic acid trays for fresh-food packaging: A Carbon Footprint assessment | 13.3 | 0 | 1 |
| Corporate Governance and the Adoption of Health Information Technology Within Integrated Delivery Systems | 13.3 | 0 | 1 |
| Ten-year risk of false positive screening mammograms and clinical breast examinations | 13.3 | 0 | 1 |
| Arthritis impact measurement scales: reliability of a French version and validity in adult Still's disease | 13.3 | 0 | 1 |
| Environmental screening of subjects with occupational exposure to organic phosphorus insecticides | 13.3 | 0 | 1 |
| Corporate carbon footprint for country Climate Change mitigation: A case study of a tannery in Turkey | 13.3 | 0 | 1 |
| Factors associated with a second deferral among donors eligible for re-entry after a false-positive screening test for syphilis, HCV, HBV and HIV. | 13.3 | 0 | 1 |
| Drugs and false-positive screening tests for porphyria | 13.3 | 0 | 1 |
| Corporate governance. Knowing me, knowing you. | 13.3 | 0 | 1 |
| Reducing Health Care's Carbon Footprint—The Power of Nursing | 13.3 | 0 | 1 |
| Practical ethics. Responsible investing | 13.3 | 0 | 1 |
| Translation and validation of the Turkish version of the arthritis impact measurement scales 2 in patients with knee osteoarthritis. | 13.3 | 0 | 1 |
| From corporate governance to hospital governance. Authority, transparency and accountability of Belgian non-profit hospitals' board and management | 13.3 | 0 | 1 |
| Psychometric properties of a Dutch short form of the Arthritis Impact Measurement Scales 2 (Dutch-AIMS2-SF). | 13.3 | 0 | 1 |
| Non-invasive coronary angiography for patients with acute atypical chest pain discharged after negative screening including maximal negative treadmill stress test. A prospective study | 13.3 | 0 | 1 |
| A new paradigm for investment screening. Four principles can help make the screening process less painful | 13.3 | 0 | 1 |
| Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire. | 13.3 | 0 | 1 |
| A comparison of two recently developed health status instruments for patients with arthritis: Dutch-AIMS2 and IRGL. Arthritis Impact Measurement Scales. Impact of Rheumatic diseases on General health and Lifestyle | 13.3 | 0 | 1 |
| Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force. | 13.3 | 0 | 1 |
| Socially responsible investing | 13.3 | 0 | 1 |
| Quality of life in rheumatoid arthritis: validation of a Spanish version of the Arthritis Impact Measurement Scales (Spanish-AIMS) | 13.3 | 0 | 1 |
| Good corporate governance is important in the fight against antibiotic resistance. Physicians and veterinarians should work together with economists and political scientists | 13.3 | 0 | 1 |
| Methodical aspects of the so-called social screening of women threatened by cervix carcinoma | 13.3 | 0 | 1 |
| Mutual funds: does past performance pay off? | 13.3 | 0 | 1 |
| Carbon footprint of conventional and organic beef production systems: An Italian case study. | 13.3 | 0 | 1 |
| Reframing social sustainability reporting: towards an engaged approach | 13.3 | 0 | 1 |
| Mutual funds--make sure they pay their way | 13.3 | 0 | 1 |
| Mutual Fund Performance | 13.3 | 0 | 1 |
| Letter to the Editor: “Comment on Hubbard and Miglioretti (2013), Consider Also a Selection Model for the Cumulative Risk of False Positive Screening Tests” | 13.3 | 0 | 1 |
| Requirement of the Pro-Cys-His-Arg sequence for O6-methylguanine-DNA methyltransferase activity revealed by saturation mutagenesis with negative and positive screening. | 13.3 | 0 | 1 |
| Socially responsible investing. Is it successful? | 13.3 | 0 | 1 |
| Joint European Support for Sustainable Investment in City Areas | 13.3 | 0 | 1 |
| Medical and social screening of patients aged 70 to 72 by an Urban General Practice Health Team | 13.3 | 0 | 1 |
| Researcher and Author Impact Metrics: Variety, Value, and Context. | 13.3 | 0 | 1 |
| Foul tip impact attenuation of baseball catcher masks using head impact metrics. | 13.3 | 0 | 1 |
| A Practical Guide for Physicians and Health Care Workers to Reduce Their Carbon Footprint in Daily Clinical Work. | 13.3 | 0 | 1 |
| BigPicture | 13.3 | 0 | 1 |
| Climate risk index for Italy | 13.3 | 0 | 1 |
| Environmental Screening of Electrode Materials for a Rechargeable Aluminum Battery with an AlCl₃/EMIMCl Electrolyte | 13.3 | 0 | 1 |
| mutual fund | 13.3 | 0 | 1 |
| Kotak Mutual Fund | 13.3 | 0 | 1 |
| Whittier Trust Company | 13.3 | 0 | 1 |
| A new hybrid method for reducing the gap between WTW and LCA in the carbon footprint assessment of electric vehicles | 13.3 | 0 | 1 |
| Universality of scholarly impact metrics | 13.3 | 0 | 1 |
| Elevating the Role of Divestment in Socially Responsible Investing | 13.3 | 0 | 1 |
| Ethical requirement and financial interest: a literature review on socially responsible investing | 13.3 | 0 | 1 |
| Electricity carbon intensity in European Member States: Impacts on GHG emissions of electric vehicles | 13.3 | 0 | 1 |
| Canonical vine copulas in the context of modern portfolio management: Are they worth it? | 13.3 | 0 | 1 |
| Bloomberg Television | 11.5 | 1 | 0 |
| Bloomberg L.P. | 11.5 | 1 | 0 |
| Organization for Economic Cooperation and Development | 11.5 | 1 | 0 |
| IBM Lotus Sametime | 11.5 | 1 | 0 |
| IBM WebSphere Application Server | 11.5 | 1 | 0 |
| Nasdaq | 11.5 | 1 | 0 |
| arXiv | 11.5 | 1 | 0 |
| IBM Lotus SmartSuite | 11.5 | 1 | 0 |
| BlackRock | 11.5 | 1 | 0 |
| PL/I | 11.5 | 1 | 0 |
| IBM AIX | 11.5 | 1 | 0 |
| Business Insider | 11.5 | 1 | 0 |
| VSE | 11.5 | 1 | 0 |
| Morgan Stanley | 11.5 | 1 | 0 |
| Connect:Direct | 11.5 | 1 | 0 |
| PR Newswire | 11.5 | 1 | 0 |
| IBM Db2 | 11.5 | 1 | 0 |
| FTSE 100 Index | 11.5 | 1 | 0 |
| IBM Rational Application Developer | 11.5 | 1 | 0 |
| Nasdaq-100 | 11.5 | 1 | 0 |
| Invesco | 11.5 | 1 | 0 |
| Sallie Krawcheck | 11.5 | 1 | 0 |
| IBM Rational ClearCase | 11.5 | 1 | 0 |
| ING Group | 11.5 | 1 | 0 |
| Lotus 1-2-3 | 11.5 | 1 | 0 |
| Triodos Bank | 11.5 | 1 | 0 |
| Bloomberg Markets | 11.5 | 1 | 0 |
| TIAA | 11.5 | 1 | 0 |
| MSCI | 11.5 | 1 | 0 |
| International Components for Unicode | 11.5 | 1 | 0 |
| Lotus Software | 11.5 | 1 | 0 |
| Charles Schwab Corporation | 11.5 | 1 | 0 |
| IBM Lotus Domino | 11.5 | 1 | 0 |
| iShares | 11.5 | 1 | 0 |
| TD Canada Trust | 11.5 | 1 | 0 |
| Toronto-Dominion Bank | 11.5 | 1 | 0 |
| Morningstar, Inc. | 11.5 | 1 | 0 |
| Oikocredit | 11.5 | 1 | 0 |
| Transaction Processing Facility | 11.5 | 1 | 0 |
| IBM Lotus Organizer | 11.5 | 1 | 0 |
| IBM Information Management System | 11.5 | 1 | 0 |
| IBM Canada | 11.5 | 1 | 0 |
| IBM Lotus Approach | 11.5 | 1 | 0 |
| IBM Lotus Expeditor | 11.5 | 1 | 0 |
| IBM Lotus Freelance Graphics | 11.5 | 1 | 0 |
| IBM Lotus Word Pro | 11.5 | 1 | 0 |
| Ally Financial | 11.5 | 1 | 0 |
| Rational Synergy | 11.5 | 1 | 0 |
| IBM Z | 11.5 | 1 | 0 |
| Q2250075 | 11.5 | 1 | 0 |
| IBM General Parallel File System | 11.5 | 1 | 0 |
| UNIX System Services | 11.5 | 1 | 0 |
| IBM WebSphere | 11.5 | 1 | 0 |
| E-Trade | 11.5 | 1 | 0 |
| Larry Fink | 11.5 | 1 | 0 |
| PowerVM | 11.5 | 1 | 0 |
| IBM Rational Software Modeler | 11.5 | 1 | 0 |
| T. Rowe Price | 11.5 | 1 | 0 |
| TradeStation | 11.5 | 1 | 0 |
| Interactive Brokers LLC - ATS | 11.5 | 1 | 0 |
| WebSphere Portal | 11.5 | 1 | 0 |
| African Economic Outlook | 11.5 | 1 | 0 |
| AllianceBernstein | 11.5 | 1 | 0 |
| Alliant Credit Union | 11.5 | 1 | 0 |
| Ally Bank | 11.5 | 1 | 0 |
| Analyst's Notebook | 11.5 | 1 | 0 |
| As You Sow | 11.5 | 1 | 0 |
| Betterment.com | 11.5 | 1 | 0 |
| BlackRock World Mining Trust | 11.5 | 1 | 0 |
| Bloomberg Technology | 11.5 | 1 | 0 |
| Calvert Investments | 11.5 | 1 | 0 |
| Centre for International Research on Economic Tendency Surveys | 11.5 | 1 | 0 |
| Develothon | 11.5 | 1 | 0 |
| Invesco Asia Dragon Trust | 11.5 | 1 | 0 |
| Emptoris | 11.5 | 1 | 0 |
| Extreme Blue | 11.5 | 1 | 0 |
| Firstrade Securities | 11.5 | 1 | 0 |
| London Stock Exchange Group | 11.5 | 1 | 0 |
| Green America | 11.5 | 1 | 0 |
| IBM Academy of Technology | 11.5 | 1 | 0 |
| IBM Check Processing Control System | 11.5 | 1 | 0 |
| IBM India Private Limited | 11.5 | 1 | 0 |
| IBM Lotus Web Content Management | 11.5 | 1 | 0 |
| IBM PureQuery | 11.5 | 1 | 0 |
| IBM Israel | 11.5 | 1 | 0 |
| IBM Rational Rose XDE | 11.5 | 1 | 0 |
| IBM Rochester | 11.5 | 1 | 0 |
| IBM Scale-out File Services | 11.5 | 1 | 0 |
| IBM Unica NetInsight | 11.5 | 1 | 0 |
| IBM WebSphere Application Server Community Edition | 11.5 | 1 | 0 |
| IBM jStart | 11.5 | 1 | 0 |
| iSeries QSHELL | 11.5 | 1 | 0 |
| Kiplinger | 11.5 | 1 | 0 |
| Linux Technology Center | 11.5 | 1 | 0 |
| Nuveen Investments | 11.5 | 1 | 0 |
| OECD Development Centre | 11.5 | 1 | 0 |
| PowerVM Lx86 | 11.5 | 1 | 0 |
| Principles for Responsible Investment | 11.5 | 1 | 0 |
| pureXML | 11.5 | 1 | 0 |
| Religion News Service | 11.5 | 1 | 0 |
| Schroder AsiaPacific Fund | 11.5 | 1 | 0 |
| Scottrade | 11.5 | 1 | 0 |
| State Street Global Advisors | 11.5 | 1 | 0 |
| IBM Spectrum Symphony | 11.5 | 1 | 0 |
| TD Ameritrade | 11.5 | 1 | 0 |
| TD Bank | 11.5 | 1 | 0 |
| Td Securities | 11.5 | 1 | 0 |
| The Motley Fool | 11.5 | 1 | 0 |
| IBM BigFix | 11.5 | 1 | 0 |
| WDCH-FM | 11.5 | 1 | 0 |
| Wikinvest | 11.5 | 1 | 0 |
| IBM Business Consulting Services | 11.5 | 1 | 0 |
| Q11506206 | 11.5 | 1 | 0 |
| IBM Japan | 11.5 | 1 | 0 |
| IBM Korea | 11.5 | 1 | 0 |
| IBM POWER | 11.5 | 1 | 0 |
| Bloomberg News | 11.5 | 1 | 0 |
| Programme for the International Assessment of Adult Competencies | 11.5 | 1 | 0 |
| BTCC | 11.5 | 1 | 0 |
| IBM i | 11.5 | 1 | 0 |
| Journal of Business Cycle Measurement and Analysis | 11.5 | 1 | 0 |
| IBM Deutschland Mittelstand Services | 11.5 | 1 | 0 |
| Mark Beech | 11.5 | 1 | 0 |
| IBM Denmark | 11.5 | 1 | 0 |
| IBM FlashSystem | 11.5 | 1 | 0 |
| Tealeaf | 11.5 | 1 | 0 |
| Hesburgh Award | 11.5 | 1 | 0 |
| Impax Asset Management Group | 11.5 | 1 | 0 |
| SoFi | 11.5 | 1 | 0 |
| IBM cloud computing | 11.5 | 1 | 0 |
| Economic Outlook | 11.5 | 1 | 0 |
| Pax World Funds | 11.5 | 1 | 0 |
| FutureAdvisor | 11.5 | 1 | 0 |
| Robinhood | 11.5 | 1 | 0 |
| Wealthfront | 11.5 | 1 | 0 |
| UBS AG, Group Historical Archives, Historisches Konzernarchiv | 11.5 | 1 | 0 |
| Openfolio | 11.5 | 1 | 0 |
| Interactive Brokers | 11.5 | 1 | 0 |
| IBM API Management | 11.5 | 1 | 0 |
| Personal Capital | 11.5 | 1 | 0 |
| Wealthsimple | 11.5 | 1 | 0 |
| TradingView | 11.5 | 1 | 0 |
| Envestnet | 11.5 | 1 | 0 |
| Eye to Eye | 11.5 | 1 | 0 |
| Hedgeable | 11.5 | 1 | 0 |
| High Flyers | 11.5 | 1 | 0 |
| Aladdin | 11.5 | 1 | 0 |
| Centre for Tax Policy and Administration | 11.5 | 1 | 0 |
| Health at a glance : OECD indicators | 11.5 | 1 | 0 |
| Health at a glance OECD indicators ... Organisation for Economic Co-operation and Development | 11.5 | 1 | 0 |
| IBM France | 11.5 | 1 | 0 |
| Companhia IBM Portuguesa | 11.5 | 1 | 0 |
| IBM Nederland | 11.5 | 1 | 0 |
| IBM Germany | 11.5 | 1 | 0 |
| IBM Egypt Business Support Services | 11.5 | 1 | 0 |
| Empower Retirement | 11.5 | 1 | 0 |
| Bloomberg Billionaires Index | 11.5 | 1 | 0 |
| IBM Česká republika | 11.5 | 1 | 0 |
| IBM Plex | 11.5 | 1 | 0 |
| UBS Optimus Foundation | 11.5 | 1 | 0 |
| IBM Studios | 11.5 | 1 | 0 |
| Sustainalytics | 11.5 | 1 | 0 |
| FER+ | 11.5 | 1 | 0 |
| Uranium | 11.5 | 1 | 0 |
| Society at a Glance | 11.5 | 1 | 0 |
| Human Interaction Network Ontology | 11.5 | 1 | 0 |
| Ontology of Social Participation | 11.5 | 1 | 0 |
| IBM (Ireland) | 11.5 | 1 | 0 |
| Maximo | 11.5 | 1 | 0 |